Filter
245
Filtered Results: 245
Text search:
non-inferiority
Featured
Recommendations
22
New Publications
38
Language
Document type
No document type
106
Studies & Reports
48
Guidelines
48
Manuals
15
Strategic & Response Plan
13
Fact sheets
6
Situation Updates
4
Training Material
3
Resource Platforms
1
Infographics
1
Countries / Regions
Global
7
India
6
Ukraine
6
Tanzania
5
Kenya
4
South Africa
4
Latin America and the Carribbean
4
Ethiopia
3
Philippines
3
South Sudan
3
Zambia
3
Malawi
3
Brazil
3
Myanmar / Burma
3
Congo, Democratic Republic of
2
Zimbabwe
2
Western and Central Europe
2
Africa
2
Burkina Faso
1
Sierra Leone
1
Liberia
1
Nigeria
1
Ghana
1
Uganda
1
Afghanistan
1
Germany
1
Thailand
1
Rwanda
1
Indonesia
1
Bangladesh
1
Papua New Guinea
1
Central African Republic
1
Angola
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Italy
1
Southern Africa
1
Canada
1
Timor Leste/ East Timor
1
Russia
1
Mauritius
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
55
Clinical Guidelines
53
Public Health
15
Women & Child Health
14
Pharmacy & Technologies
5
Key Resources
4
Capacity Building
3
Toolboxes
HIV
35
COVID-19
30
TB
27
NTDs
18
Mental Health
13
AMR
8
NCDs
7
Rapid Response
6
Caregiver
6
Disability
5
Cholera
5
Conflict
5
Planetary Health
5
Refugee
4
Pharmacy
4
Polio
3
Ebola
2
Social Ethics
2
Global Health Education
1
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
Int J Crit Illn Inj Sci. 2012 May-Aug; 2(2): 82–97.
doi: 10.4103/2229-5151.97273
PMCID: PMC3401822
PMID: 22837896
People with mental disorders in low-income countries are at risk of being left behind during efforts to expand universal health coverage. Aim is to propose context-relevant strategies for moving towards universal health coverage for people with mental disorders in Ethiopia.
В борьбе с туберкулезом достигнуты значительные прорывы, среди которых ускоренные и более точные методы диагностики и первые новые лекарственные средства за 50 л...
Mission report April 2016
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0189770 January 2, 2018
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
Agenda item 5, UNAIDS/PCB (43)/18.
11-13 December 2018 | Geneva, Switzerland
UNAIDS Programme Coordinating Board
Issue date: 23 November 2018
Accessed February 6, 2020
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
HIV/AIDS Programme
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of policy recommendation...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
